Raising the bar: incorporating patient preferences in treatment decisions for RA  

October 12th 2021
17:00 CEST

The Event

Disclaimer: This page is for Health Care Professionals only.

Raising the bar: incorporating patient preferences in treatment decisions for RA  

This webinar, taking place between 17:00–17:45 CEST on Tuesday 12 October, will be a discursive, practice-oriented session with Prof. Rieke Alten and Prof. Bruno Fautrel. Using a patient case study, the expert faculty will explore patients’ preferences and expectations for rheumatoid arthritis treatment and provide practical guidance on how to utilise this information to provide a patient-centred approach to decision making in daily clinical practice. This webinar includes a live Q&A.


Professor Dr Rieke Alten
Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany

Professor Dr Rieke Alten is Professor of Medicine and Head of the Department of Internal Medicine, Rheumatology, Clinical Immunology, Osteology at Schlosspark-Klinik, University Medicine Berlin, where she is also Director of the Rheumatology Research Centre. Her research focuses on the development and systematic evaluation of biological and immunomodulatory treatments for rheumatic diseases. She has published >200 original papers, book chapters and reviews, has led >100 clinical trials of novel therapies in rheumatic diseases and has contributed to several investigator-initiated trials. 

Professor Bruno Fautrel
Pitié-Salpêtrière University Hospital, Sorbonne University/Assistance Publique–Hôpitaux de Paris, Paris, France

Professor Bruno Fautrel is Professor of Rheumatology and Head of the Department of Rheumatology at the Pitié-Salpêtrière University Hospital. He was formerly Head of the ESPOIR Cohort Scientific Committee (2008–2010) and the Scientific Committee of the French Society for Rheumatology (2010–2011). He was PI of two multicentre trials on the decline of targeted RA therapies and was coordinating investigator of a European project on a multiomic approach to autoinflammatory disease diagnosis. He is also Co-director of IMIDIATE, a national network dedicated to clinical investigations in IMIDs.


Supporting materials

During the event, you will find all supporting material on the webinar website.


See all our events